Phase 3 Readout~month

Phase 3 Topline: RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and e

Indication
Hepatitis

Other upcoming events for BHC

Patent ExpiryPatent/Exclusivity Expiry: CLINDESSE
Patent ExpiryPatent/Exclusivity Expiry: XIMINO
Patent ExpiryPatent/Exclusivity Expiry: CHLORAPREP ONE-STEP
Patent ExpiryPatent/Exclusivity Expiry: CHLORHEXIDINE GLUCONATE
Patent ExpiryPatent/Exclusivity Expiry: OLUX E

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and e — BHC Phase 3 Readout | BioSniper